NF-1, Nutraceutical Intervention

Running, not enrolling · Phase 1

Conditions studied: Neurofibromatosis 1

In brief

The treatment plan is identical for all participants with the exception of the curcumin dose level that is assigned at study enrollment. Participants are instructed to take the curcumin and olive oil one after the other (order does not matter) twice a day on an empty stomach ideally 30 minutes before breakfast and dinner. Curcumin and high phenolic extra virgin olive oil (HP-EVOO) may continue for up to 12 months in the absence of unacceptable side effects.

Key facts

Study ID
NCT05363267
Run by
Masonic Cancer Center, University of Minnesota
People needed
23
Starts
2022-07-06
Expected to finish
2026-08-01
Last updated by the study team
2026-06-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.